PMID: 4620977Oct 1, 1974Paper

The mechanisms of action of L-dopa in Parkinson's disease

Life Sciences
O Hornykiewicz


No abstract listed.


Feb 13, 1969·The New England Journal of Medicine·G C CotziasR Gellene
Sep 15, 1973·Biochemical Pharmacology·A C CollinsV E Davis
Apr 23, 1971·Nature·G BartholiniA Pletscher
Feb 1, 1970·Biochemical Medicine·T L Sourkes
Jan 1, 1971·Psychopharmacologia·J MajE Mogilnicka
Sep 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·W DairmanS Udenfriend
Oct 2, 1970·Science·K Y NgI J Kopin
Jul 1, 1966·Acta Physiologica Scandinavica·N E AndénT Hökfelt
Feb 28, 1958·Science·A CARLSSONB WALDECK
Nov 26, 2010·The Journal of Physical Chemistry. a·Anita LagutschenkovOtto Dopfer

❮ Previous
Next ❯


May 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·J Opacka-Juffry, D J Brooks
Jan 1, 1984·Journal of Neurology·P JeantyH De Bruyne
Dec 15, 1978·Psychopharmacology·P Muller, P Seeman
Jan 29, 1981·European Journal of Pharmacology·J H PazoJ H Medina
Oct 1, 1976·Pharmacology, Biochemistry, and Behavior·A DolphinC D Marsden
Aug 1, 1980·Pharmacology, Biochemistry, and Behavior·C Duncan, R A Deitrich
Jun 1, 1984·Pharmacology, Biochemistry, and Behavior·P E GilliamR P Farrar
Apr 11, 1991·Pharmacology, Biochemistry, and Behavior·M S Lawrence, D E Redmond
Jan 1, 1989·Progress in Neuro-psychopharmacology & Biological Psychiatry·S Wolfarth, K Ossowska
Jan 1, 1983·Progress in Neurobiology·R H FishmanH L Klawans
Jun 29, 1988·Neuroscience Letters·G S Robertson, H A Robertson
Jan 1, 1986·General Pharmacology·R Michalek, D Templeton
Jan 1, 1984·Brain Research Bulletin·E L GasteigerH Brust-Carmona
Mar 27, 2004·European Journal of Pharmacology·Shou Yu YinMyung Koo Lee
Apr 20, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Keiko Ikemoto
Oct 18, 2003·Biochemical Pharmacology·Jae Joon LeeMyung Koo Lee
Oct 14, 2003·Experimental Neurology·Timothy J CollierJeffrey H Kordower
Aug 29, 1997·Neuroscience Letters·K IkemotoI Nagatsu
Jan 22, 2000·Brain Research Bulletin·J H Kordower, C G Goetz
Sep 19, 1998·Free Radical Biology & Medicine·J S Kim-Han, A Y Sun

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.